| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9ff587a05b610df0a4268d2fc89b5c92 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2795-00051
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2795-10151
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2795-10122 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-02 |
| filingDate |
2011-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f742667d74905a4de5e45bcd76f32c14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5efe8cf128472385e8c965b635d9e218
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_11f0d104a914274afb88b635acc9a420
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34d01e8c2b1543594d6e4319e47826c1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce0e063a0f03a39163c74fcfef509764
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14b7bc1364aa7177a1bbcfebb99fc8a0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f41dd1c2b0a42c2dd63c1a99b9ba7a19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_64208c3581827ec850d514a3c14a9816 |
| publicationDate |
2013-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2632940-A1 |
| titleOfInvention |
A method of producing bacteriophage preparations comprising purification using affinity chromatography |
| abstract |
The proposed method facilitates the single-stage and at the same time effective purification of phage preparations for therapeutic uses, and facilitates the maintenance of bacteriophage antibacterial activity both in the case of displacement of the bacteriophage from the resin and its proteolytic release. The protein modification of the phage capsid with appropriate binding motifs makes it possible to purify therapeutically bacteriophage strains using affinity chromatography. The proposed method is useful in the display of selected polypeptided on a bacteriophage capsid without the need to genetically modify the bacteriophage, and thus makes it possible to produce phage preparations for various uses using wild-type phages occurring naturally or others not additionally modified for phage-display purposes. |
| priorityDate |
2010-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |